Pyxis Oncology Stock (NASDAQ: PYXS) stock price, news, charts, stock research, profile.
Open | $4.550 |
Close | $4.500 |
Volume / Avg. | 384.040K / 919.401K |
Day Range | 4.435 - 4.725 |
52 Wk Range | 1.350 - 6.850 |
Market Cap | $258.112M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 5.58% |
Days to Cover | 2.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pyxis Oncology (NASDAQ: PYXS) through any online brokerage.
Other companies in Pyxis Oncology’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Tevogen Bio Holdings (NASDAQ:TVGN).
The latest price target for Pyxis Oncology (NASDAQ: PYXS) was reported by HC Wainwright & Co. on Wednesday, April 10, 2024. The analyst firm set a price target for 7.00 expecting PYXS to rise to within 12 months (a possible 57.66% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Pyxis Oncology (NASDAQ: PYXS) is $4.44 last updated April 22, 2024 at 4:19 PM EDT.
There are no upcoming dividends for Pyxis Oncology.
Pyxis Oncology’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Pyxis Oncology.
Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.